Erratum to: E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer

被引:0
|
作者
Hsin-An Chen
Yi-Wen Chang
Chi-Feng Tseng
Ching-Feng Chiu
Chih-Chen Hong
Weu Wang
Ming-Yang Wang
Michael Hsiao
Jui-Ti Ma
Chung-Hsing Chen
Shih-Sheng Jiang
Chih-Hsiung Wu
Mien-Chie Hung
Ming-Te Huang
Jen-Liang Su
机构
[1] National Health Research Institutes,National Institute of Cancer Research
[2] Taipei Medical University,Graduate Institute of Clinical Medicine, College of Medicine
[3] Taipei Medical University,Division of General Surgery, Department of Surgery, Shuang Ho Hospital
[4] National Yang-Ming University,Graduate Institute of Biochemistry and Molecular Biology
[5] Genomics Research Center,Department of Surgery, Taipei Medical University Hospital
[6] Taipei Medical University,Department of Surgery
[7] National Taiwan University Hospital,Department of Molecular and Cellular Oncology
[8] The University of Texas MD Anderson Cancer Center,Graduate Institute of Cancer Biology
[9] China Medical University,Center for Molecular Medicine
[10] China Medical University Hospital,Department of Biotechnology
[11] Asia University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:685 / 686
页数:1
相关论文
共 50 条
  • [31] Novel ROR1 inhibitor CPD86 suppresses cell survival and migration in triple-negative breast cancer
    Ta, T.
    Gupta, S. R. R.
    Reed, V.
    Scanlon, C.
    Fultang, N.
    Peethambaran, B.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 965 - 966
  • [32] Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
    Yan Zhou
    Shuchen Lin
    Kuo-Fu Tseng
    Kun Han
    Yaling Wang
    Zhi-hua Gan
    Da-liu Min
    Hai-yan Hu
    BMC Cancer, 16
  • [33] Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
    Zhou, Yan
    Lin, Shuchen
    Tseng, Kuo-Fu
    Han, Kun
    Wang, Yaling
    Gan, Zhi-hua
    Min, Da-liu
    Hu, Hai-yan
    BMC CANCER, 2016, 16
  • [34] Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition
    Raninga, Prahlad
    Lee, Andy
    Sinha, Debottam
    Dong, Lan-feng
    Datta, Keshava
    Lu, Xue
    Kalita-de Croft, Priyakshi
    Dutt, Mriga
    Hill, Michelle M.
    Pouliot, Normand M.
    Gowda, Harsha
    Kalimutho, Murugan
    Neuzil, Jiri
    Khanna, Kum Kum
    THERANOSTICS, 2020, 10 (12): : 5259 - 5275
  • [35] Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer
    Lv, Zhi-Dong
    Yang, Zhao-Chuan
    Liu, Xiang-Ping
    Jin, Li-Ying
    Dong, Qian
    Qu, Hui-Li
    Li, Fu-Nian
    Kong, Bin
    Sun, Jiao
    Zhao, Jiao-Jiao
    Wang, Hai-Bo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (09) : 1640 - 1650
  • [36] LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1
    Wang, Jiangfen
    Xi, Chunfang
    Yang, Xuan
    Lu, Xiaoting
    Yu, Keda
    Zhang, Yafen
    Gao, Runfang
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (10) : 671 - 675
  • [37] MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and In Vitro Study
    Tebbi, Leila
    Mansoori, Behzad
    Safaei, Sahar
    Hashemzadeh, Shahriar
    Shirmohamadi, Masoud
    Hajiasgharzadeh, Khalil
    Shadbad, Mahdi Abdoli
    Baradaran, Behzad
    ADVANCED PHARMACEUTICAL BULLETIN, 2022, 12 (04) : 842 - 849
  • [38] AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
    Chen, Bo
    Wang, Jin
    Dai, Danian
    Zhou, Qingyu
    Guo, Xiaofang
    Tian, Zhi
    Huang, Xiaojia
    Yang, Lu
    Tang, Hailin
    Xie, Xiaoming
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [39] Met and HGF inhibition in triple-negative breast cancer cell lines
    Gaule, Patricia Brid
    Collins, Denis
    Walsh, Naomi
    Duffy, Michael J.
    Crown, John
    O'Donovan, Norma
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
    Bo Chen
    Jin Wang
    Danian Dai
    Qingyu Zhou
    Xiaofang Guo
    Zhi Tian
    Xiaojia Huang
    Lu Yang
    Hailin Tang
    Xiaoming Xie
    Journal of Experimental & Clinical Cancer Research, 36